Disc Medicine, Inc. (IRON)

Disc Medicine Statistics

Total Valuation

Disc Medicine has a market cap or net worth of $3.02 billion. The enterprise value is $2.33 billion.

Market Cap	3.02B
Enterprise Value	2.33B

Important Dates

The last earnings date was Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Disc Medicine has 37.75 million shares outstanding. The number of shares has increased by 27.33% in one year.

Current Share Class	37.75M
Shares Outstanding	37.75M
Shares Change (YoY)	+27.33%
Shares Change (QoQ)	+0.44%
Owned by Insiders (%)	1.04%
Owned by Institutions (%)	91.78%
Float	34.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.52
P/TBV Ratio	5.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 23.45, with a Debt / Equity ratio of 0.05.

Current Ratio	23.45
Quick Ratio	23.03
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-61.77

Financial Efficiency

Return on equity (ROE) is -34.78% and return on invested capital (ROIC) is -23.69%.

Return on Equity (ROE)	-34.78%
Return on Assets (ROA)	-22.61%
Return on Invested Capital (ROIC)	-23.69%
Return on Capital Employed (ROCE)	-33.73%
Revenue Per Employee	n/a
Profits Per Employee	-$2.16M
Employee Count	84
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Disc Medicine has paid $449,000 in taxes.

Income Tax	449,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.86% in the last 52 weeks. The beta is 2.51, so Disc Medicine's price volatility has been higher than the market average.

Beta (5Y)	2.51
52-Week Price Change	+23.86%
50-Day Moving Average	87.46
200-Day Moving Average	62.34
Relative Strength Index (RSI)	32.13
Average Volume (20 Days)	704,748

Short Selling Information

The latest short interest is 2.59 million, so 6.85% of the outstanding shares have been sold short.

Short Interest	2.59M
Short Previous Month	3.02M
Short % of Shares Out	6.85%
Short % of Float	7.49%
Short Ratio (days to cover)	5.12

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-203.60M
Pretax Income	-180.66M
Net Income	-181.11M
EBITDA	-203.40M
EBIT	-203.60M
Earnings Per Share (EPS)	-$5.42

Balance Sheet

The company has $615.92 million in cash and $30.98 million in debt, giving a net cash position of $584.94 million or $15.50 per share.

Cash & Cash Equivalents	615.92M
Total Debt	30.98M
Net Cash	584.94M
Net Cash Per Share	$15.50
Equity (Book Value)	573.39M
Book Value Per Share	16.38
Working Capital	600.42M

Cash Flow

In the last 12 months, operating cash flow was -$164.67 million and capital expenditures -$1.36 million, giving a free cash flow of -$166.03 million.

Operating Cash Flow	-164.67M
Capital Expenditures	-1.36M
Free Cash Flow	-166.03M
FCF Per Share	-$4.40

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Disc Medicine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.33%
Shareholder Yield	-27.33%
Earnings Yield	-6.20%
FCF Yield	-5.69%

Analyst Forecast

The average price target for Disc Medicine is $108.85, which is 36.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$108.85
Price Target Difference	36.00%
Analyst Consensus	Strong Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2